Microutrophin expression in dystrophic mice displays myofiber type differences in therapeutic effects

por Banks, Glen B., Chamberlain, Jeffrey S., Odom, Guy L.
Publicado 2020

Extracorporeal Delivery of rAAV with Metabolic Exchange and Oxygenation

por Bieber, Scott, Halldorson, Jeffrey B., Finn, Eric, Ahmad, Suhail, Chamberlain, Jeffrey S., Odom, Guy L.
Publicado 2013

Muscle Structure Influences Utrophin Expression in mdx Mice

por Banks, Glen B., Combs, Ariana C., Odom, Guy L., Bloch, Robert J., Chamberlain, Jeffrey S.
Publicado 2014

Adeno-associated viral vectors do not efficiently target muscle satellite cells

por Arnett, Andrea LH, Konieczny, Patryk, Ramos, Julian N, Hall, John, Odom, Guy, Yablonka-Reuveni, Zipora, Chamberlain, Joel R, Chamberlain, Jeffrey S
Publicado 2014

Gene Therapy Rescues Cardiac Dysfunction in Duchenne Muscular Dystrophy Mice by Elevating Cardiomyocyte Deoxy-Adenosine Triphosphate

por Kolwicz, Stephen C., Hall, John K., Moussavi-Harami, Farid, Chen, Xiolan, Hauschka, Stephen D., Chamberlain, Jeffrey S., Regnier, Michael, Odom, Guy L.
Publicado 2019

Biomarkers for Duchenne muscular dystrophy progression: impact of age in the mdx tongue spared muscle

por Lorena, Marcelo dos Santos Voltani, Santos, Estela Kato, Ferretti, Renato, Gowda, G.A. Nagana, Odom, Guy L., Chamberlain, Jeffrey S., Matsumura, Cintia Yuri
Publicado 2023

Biomarkers for Duchenne muscular dystrophy progression: impact of age in the mdx tongue spared muscle

por Lorena, Marcelo dos Santos Voltani, Santos, Estela Kato dos, Ferretti, Renato, Nagana Gowda, G. A., Odom, Guy L., Chamberlain, Jeffrey S., Matsumura, Cintia Yuri
Publicado 2023

Micro-utrophin Improves Cardiac and Skeletal Muscle Function of Severely Affected D2/mdx Mice

por Kennedy, Tahnee L., Guiraud, Simon, Edwards, Ben, Squire, Sarah, Moir, Lee, Babbs, Arran, Odom, Guy, Golebiowski, Diane, Schneider, Joel, Chamberlain, Jeffrey S., Davies, Kay E.
Publicado 2018

Muscle-specific CRISPR/Cas9 dystrophin gene editing ameliorates pathophysiology in a mouse model for Duchenne muscular dystrophy

por Bengtsson, Niclas E., Hall, John K., Odom, Guy L., Phelps, Michael P., Andrus, Colin R., Hawkins, R. David, Hauschka, Stephen D., Chamberlain, Joel R., Chamberlain, Jeffrey S.
Publicado 2017

Translation of Cardiac Myosin Activation With 2-Deoxy-ATP to Treat Heart Failure Via an Experimental Ribonucleotide Reductase-Based Gene Therapy

por Thomson, Kassandra S., Odom, Guy L., Murry, Charles E., Mahairas, Gregory G., Moussavi-Harami, Farid, Teichman, Sam L., Chen, Xiaolan, Hauschka, Stephen D., Chamberlain, Jeffrey S., Regnier, Michael
Publicado 2016

Corrigendum: Muscle-specific CRISPR/Cas9 dystrophin gene editing ameliorates pathophysiology in a mouse model for Duchenne muscular dystrophy

por Bengtsson, Niclas E., Hall, John K., Odom, Guy L., Phelps, Michael P., Andrus, Colin R., Hawkins, R. David, Hauschka, Stephen D., Chamberlain, Joel R., Chamberlain, Jeffrey S.
Publicado 2017

Micro-dystrophin gene therapy prevents heart failure in an improved Duchenne muscular dystrophy cardiomyopathy mouse model

por Howard, Zachary M., Dorn, Lisa E., Lowe, Jeovanna, Gertzen, Megan D., Ciccone, Pierce, Rastogi, Neha, Odom, Guy L., Accornero, Federica, Chamberlain, Jeffrey S., Rafael-Fortney, Jill A.
Publicado 2021

Micro-dystrophin gene therapy demonstrates long-term cardiac efficacy in a severe Duchenne muscular dystrophy model

por Piepho, Arden B., Lowe, Jeovanna, Cumby, Laurel R., Dorn, Lisa E., Lake, Dana M., Rastogi, Neha, Gertzen, Megan D., Sturgill, Sarah L., Odom, Guy L., Ziolo, Mark T., Accornero, Federica, Chamberlain, Jeffrey S., Rafael-Fortney, Jill A.
Publicado 2023

Cell based dATP delivery as a therapy for chronic heart failure

por Mhatre, Ketaki N, Mathieu, Julie, Martinson, Amy, Flint, Galina, Blakley, Leslie P, Tabesh, Arash, Reinecke, Hans, Yang, Xiulan, Guan, Xuan, Murali, Eesha, Klaiman, Jordan M, Odom, Guy L, Brown, Mary Beth, Tian, Rong, Hauschka, Stephen D, Raftery, Daniel, Moussavi-Harami, Farid, Regnier, Michael, Murry, Charles E
Publicado 2023